Scoat Pharma Private Limited, a active private limited company, was established on 10 April 2006 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2006PTC049786. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 15 professional, Its leadership includes Kolla Ramalingeswara Anand Swarup (Additional Director), Javvaji Devi Aruna (Director), Padmaja Rani Manepalli (Director). Past directors included Padmaja Ommi, Kolla Ramalingeswara Anand Swarup, Padmaja Rani Manepalli. It holds ₹13.00 Cr open charges and ₹3.49 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.54, A - Leap Industrial Area,Survey No.342 Gajularamaram, Quthbullapur Mandal,, Hyderabad, Telangana, 500072.
U24239TG2006PTC049786
049786
10 April 2006
₹1.00 Cr
₹1.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Scoat Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kolla Ramalingeswara Anand Swarup | Additional Director | 24 Nov 2023 | Current |
| Javvaji Devi Aruna | Director | 06 Jan 2011 | Current |
| Padmaja Rani Manepalli | Director | 28 Nov 2015 | Current |
| Javvaji Anil Kumar Gupta | Director | 17 Dec 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jul 2014 | Past |
| Pramod Abcsdd | Director | 28 Nov 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 28 Jul 2014 | Past |
| Pramod Abcsdd | Director | 20 Jun 2009 | Past |
| Pramod Abcsdd | Director | 06 Jan 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scoat Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 16.33% increase. The company also saw a substantial improvement in profitability, with a 61.04% increase in profit. The company's net worth Soared by an impressive increase of 58.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Scoat Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹130,000,000.00
₹3,490,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2024 | Others | ₹7.00 Cr | Open |
| 14 Feb 2024 | Others | ₹1.00 Cr | Open |
| 22 Aug 2015 | Others | ₹5.00 Cr | Open |
| 10 Jun 2020 | Others | ₹3.49 M | Satisfied |
Explore comprehensive loan charge details -
Scoat Pharma has a workforce of 15 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Scoat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scoat Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 5.00 Cr registered on 22 Aug 2015 with Charge ID 10592307 was modified on 31 May 2025. was completed.
Scoat Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Scoat Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with Others amounted to Rs. 7.00 Cr with Charge ID 100879363 was registered on 14 Feb 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100879347 was registered on 14 Feb 2024. was recorded as a recent event.
A charge registered on 10 Jun 2020 via Charge ID 100347071 with Others was fully satisfied on 15 Dec 2023. was recorded as a recent event.
The CIN of Scoat Pharma Private Limited is U24239TG2006PTC049786.
Scoat Pharma Private Limited is headquartered at Plot No.54, A - Leap Industrial Area,Survey No.342 Gajularamaram, Quthbullapur Mandal,, Hyderabad, Telangana, 500072.
Scoat Pharma Private Limited was incorporated on 10 April 2006.
The current directors of Scoat Pharma Private Limited are
The primary industry of Scoat Pharma Private Limited is Manufacturing.
Scoat Pharma Private Limited is unlisted.
The authorized capital of Scoat Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Scoat Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX